title: Effect of amino-oxyacetic acid (AOAA) on focal penicillin seizures.
abstract: The biochemical and behavioral effects of the anticonvulsant amino-oxyacetic acid (AOAA) have been studied in a model of focal penicillin seizures in rats. At 20 mg/Kg AOAA treatment results in a progressive 11 fold increase in GABA levels in cortex over three hours. There is a decrease in aspartate, ketoglutarate, alanine and glutamine, and an initial decrease followed by an increase in pyruvate and glutamate. These results reflect a functional inhibition of several B-6 dependent aminotransferase enzymes. When rats are pretreated 30 min before the onset of focal penicillin seizures there is a 60% reduction in the number of discharges and a 34% reduction in seizure duration. Pretreatment beyond 75 min results in progressively less anticonvulsant effect, such that seizures eventually become more severe than control. There is an increase in the number and duration of discharges, seizure spikes become complex, and tonic-clonic events develop. Penicillin seizures do not cause a change in levels of GABA, but result in a decrease in glutamate within the focus. AOAA pretreatment initially prevents this decrease in glutamate but later accentuates it. The biochemical effects of AOAA are complex, but biphasic anticonvulsant properties coincide in time with a change in the balance of excitatory and inhibitory amino acids in the seizure focus.
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000409:Alanine / Q000378:metabolism; D000625:Aminooxyacetic Acid / Q000627:therapeutic use*; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D004195:Disease Models, Animal; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005971:Glutamates / Q000378:metabolism; D005973:Glutamine / Q000378:metabolism; D007656:Ketoglutaric Acids / Q000378:metabolism; D010406:Penicillins; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors; D000637:Transaminases / Q000037:antagonists & inhibitors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
chemical_list: D000085:Acetates; D005971:Glutamates; D007656:Ketoglutaric Acids; D010406:Penicillins; D011773:Pyruvates; D005973:Glutamine; D000625:Aminooxyacetic Acid; D001224:Aspartic Acid; D005680:gamma-Aminobutyric Acid; D000637:Transaminases; D000409:Alanine